Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Falk Ehmann

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
British Journal of Clinical Pharmacology|April 21, 2020
Commentary on ICH guideline on genomic sampling and data management-enabling opportunities in drug development and patient treatmentFalk Ehmann, Jeroen Aerssens, Rebecca Blanchard
British Journal of Clinical Pharmacology|January 18, 2014
European Medicines Agency initiatives and perspectives on pharmacogenomicsFalk Ehmann, Laura Caneva, Marisa Papaluca
The AAPS Journal|August 17, 2016
Nanomedicines in the EU-Regulatory OverviewRuben Pita, Falk Ehmann, Marisa Papaluca
Frontiers in Pharmacology|December 4, 2024
Identifying and overcoming challenges in the EMA's qualification of novel methodologies: a two-year reviewAna Drmić, Riccardo Saccà, Thorsten Vetter, et al.
Therapeutic Innovation & Regulatory Science|August 30, 2024
Insights into Early Interactions on Innovative Developments with European RegulatorsDavid W Uster, Valentina Cordo', Emmanuel Cormier, et al.
Expert Review of Clinical Pharmacology|March 24, 2015
White spots in pharmaceutical pipelines-EMA identifies potential areas of unmet medical needsMarisa Papaluca, Martina Greco, Enrico Tognana, et al.
Frontiers in Medicine|May 13, 2022
Biomarkers in Medicines Development-From Discovery to Regulatory Qualification and BeyondNatalie M Hendrikse, Jordi Llinares Garcia, Thorsten Vetter, et al.
Frontiers in Medicine|November 18, 2021
Biomarker and Companion Diagnostics-A Review of Medicinal Products Approved by the European Medicines AgencyLaura Patricia Orellana García, Falk Ehmann, Philip A Hines, et al.
Expert Opinion on Pharmacotherapy|March 17, 2015
Changes and determination of dosing recommendations for medicinal products recently authorised in the European UnionFalk Ehmann, Marisa Papaluca, Francesca Di Giuseppe, et al.
Frontiers in Medicine|March 27, 2023
Enabling technologies driving drug research and developmentPanna Vass, Dara Sevkan Akdag, Gabriel Enemark Broholm, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
British Journal of Clinical Pharmacology|April 21, 2020
Commentary on ICH guideline on genomic sampling and data management-enabling opportunities in drug development and patient treatmentFalk Ehmann, Jeroen Aerssens, Rebecca Blanchard
British Journal of Clinical Pharmacology|January 18, 2014
European Medicines Agency initiatives and perspectives on pharmacogenomicsFalk Ehmann, Laura Caneva, Marisa Papaluca
The AAPS Journal|August 17, 2016
Nanomedicines in the EU-Regulatory OverviewRuben Pita, Falk Ehmann, Marisa Papaluca
Frontiers in Pharmacology|December 4, 2024
Identifying and overcoming challenges in the EMA's qualification of novel methodologies: a two-year reviewAna Drmić, Riccardo Saccà, Thorsten Vetter, et al.
Therapeutic Innovation & Regulatory Science|August 30, 2024
Insights into Early Interactions on Innovative Developments with European RegulatorsDavid W Uster, Valentina Cordo', Emmanuel Cormier, et al.
Expert Review of Clinical Pharmacology|March 24, 2015
White spots in pharmaceutical pipelines-EMA identifies potential areas of unmet medical needsMarisa Papaluca, Martina Greco, Enrico Tognana, et al.
Frontiers in Medicine|May 13, 2022
Biomarkers in Medicines Development-From Discovery to Regulatory Qualification and BeyondNatalie M Hendrikse, Jordi Llinares Garcia, Thorsten Vetter, et al.
Frontiers in Medicine|November 18, 2021
Biomarker and Companion Diagnostics-A Review of Medicinal Products Approved by the European Medicines AgencyLaura Patricia Orellana García, Falk Ehmann, Philip A Hines, et al.
Expert Opinion on Pharmacotherapy|March 17, 2015
Changes and determination of dosing recommendations for medicinal products recently authorised in the European UnionFalk Ehmann, Marisa Papaluca, Francesca Di Giuseppe, et al.
Frontiers in Medicine|March 27, 2023
Enabling technologies driving drug research and developmentPanna Vass, Dara Sevkan Akdag, Gabriel Enemark Broholm, et al.
Pageof 2